Anatom Holding acquires 4.9% shareholding in BioGaia

BioGaia AB (NASDAQ: BIOG) announces that Anatom Holding AG, a Switzerland-based investment firm, has acquired 4,979,813 class B shares in BioGaia AB following the exit of EQT Public Value fund. This acquisition represents 4.9% of BioGaia’s total shares and 3.7% of the total voting rights. The transaction, which is not subject to any conditions, was completed on October 31, 2024.

BioGaia, a global leader in probiotics, welcomes Anatom Holding as a long-term investor. Anatom Holding, an independent investment firm managed by the Kahane Family, specializes in providing strategic capital to high-potential growth companies. With deep experience in the health and ingredients sectors, Anatom Holding’s investment reflects confidence in BioGaia’s robust market position and growth fueled by ongoing innovation in the probiotic segment.

Peter Rothschild, Chairman of BioGaia, comments: “We are pleased to welcome Anatom Holding, known for its long-term partnerships with industry leaders, as a valued investor in BioGaia. We look forward to leveraging Anatom Holding’s expertise in the health sector as we continue to expand our global reach and influence in consumer health”.

Following the transaction, the shares will be held by Anatom Holding and other entities controlled by the Kahane Family, underscoring their commitment to BioGaia’s long-term success in the consumer health market.
 

Follow us:
Subscribe to BioGaia press releases here
LinkedIn here

Contacts:
Peter Rothschild, Chairman of the Board
Email: pr@biogaia.se
Phone: +46 708 30 65 40

About BioGaia
BioGaia is a Swedish probiotic company that has been at the forefront of microbiome research for more than 30 years. BioGaia develops, markets, and sells probiotic products focused on gut health, immune health, and oral health. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaiagroup.com